Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://haleemaxqmi700783.ttblogs.com/18854729/semaglutide-a-potential-solution-for-metabolic-disorders